0001181431-13-062018.txt : 20131209
0001181431-13-062018.hdr.sgml : 20131209
20131209191007
ACCESSION NUMBER: 0001181431-13-062018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131205
FILED AS OF DATE: 20131209
DATE AS OF CHANGE: 20131209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HORIZON PHARMA, INC.
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 LAKE COOK ROAD
STREET 2: SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
BUSINESS PHONE: 224-383-3000
MAIL ADDRESS:
STREET 1: 520 LAKE COOK ROAD
STREET 2: SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH TODD N
CENTRAL INDEX KEY: 0001523672
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 131266738
MAIL ADDRESS:
STREET 1: 1033 SKOKIE BOULEVARD
STREET 2: SUITE 355
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
4
1
rrd396913.xml
X0306
4
2013-12-05
0
0001492426
HORIZON PHARMA, INC.
HZNP
0001523672
SMITH TODD N
C/O HORIZON PHARMA, INC.
520 LAKE COOK ROAD, SUITE 520
DEERFIELD
IL
60015
0
1
0
0
EVP & Chief Commercial Officer
Common Stock
2013-12-05
4
A
0
18037
0.0
A
48933
D
Common Stock
2013-12-09
4
M
0
3350
0
A
52283
D
Common Stock
2013-12-09
4
S
0
1322
6.79
D
50961
D
Common Stock
2013-12-09
4
S
0
10000
6.93
D
40961
D
Restricted stock units
2013-12-09
4
M
0
3350
0
D
common stock
10048
6698
D
Fully vested deferred issuance of restricted stock units provided as a one-time bonus payment in connection with the completion of the Company's acquisition of U.S. rights to VIMOVO (R).
Includes 8,326 shares of the Company's common stock acquired in June 2013 and December 2013 pursuant to an employee stock purchase program.
Reflects shares of common stock surrendered via open market sale to satisfy tax withholding obligations in connection with vesting of a restricted stock unit and the receipt of a fully vested deferred issuance stock award.
Each restricted stock units represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
On December 8, 2011, the reporting person was granted 13,397 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Robert J. DeVaere, Attorney-In-Fact
2013-12-09